Pulmonx
LUNG
113 hedge funds and large institutions have $1.14B invested in Pulmonx in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 47 increasing their positions, 21 reducing their positions, and 32 closing their positions.
124% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 21
16% more capital invested
Capital invested by funds: $988M → $1.14B (+$153M)
10.84% more ownership
Funds ownership: 60.53% → 71.37% (+11%)
3% more funds holding
Funds holding: 110 → 113 (+3)
9% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 32
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$64.9M |
| 2 |
BlackRock
New York
|
+$61.3M |
| 3 |
DM
Deerfield Management
New York
|
+$37.6M |
| 4 |
Primecap Management
Pasadena,
California
|
+$33.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AICPI
ABG Innovation Capital Partners III
Central, Hong Kong,
Hong Kong
|
-$36.1M |
| 2 |
AWGLSCP
ABG-WTT Global Life Science Capital Partners
Central, Hong Kong,
Hong Kong
|
-$31.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.3M |
| 4 |
Millennium Management
New York
|
-$14M |
| 5 |
YF
Yu Fan
|
-$13.9M |
LUNG Hedge Fund Activity: Q2 2021 in Review
113 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2021, worth a combined $1.14B — up 16% from $988M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new LUNG positions and 32 closed out — a net gain of 3 holders — while 47 added to existing stakes and 21 trimmed.
The largest buyer was Capital World Investors, adding an estimated $64.9M. The largest seller was ABG Innovation Capital Partners III, cutting an estimated $36.1M.
- 113 institutional investors held Pulmonx (LUNG) as of Q2 2021, up from 110 in Q1 2021.
- Funds reported $1.14B of Pulmonx stock for Q2 2021, up 16% quarter-over-quarter.
- 35 funds opened new Pulmonx positions in Q2 2021 and 32 closed out, a net change of +3 holders.
- The largest Pulmonx buyer in Q2 2021 was Capital World Investors, an estimated $64.9M added.
- The largest Pulmonx seller in Q2 2021 was ABG Innovation Capital Partners III, an estimated $36.1M sold.
Based on aggregated 13F filings for Q2 2021.